The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3-(4-fluoroisoindolin-2-yl)-3-methylbutyl)-2-isopropoxyphenol ID: ALA4867297
PubChem CID: 91826734
Max Phase: Preclinical
Molecular Formula: C22H28FNO2
Molecular Weight: 357.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)Oc1cc(CCC(C)(C)N2Cc3cccc(F)c3C2)ccc1O
Standard InChI: InChI=1S/C22H28FNO2/c1-15(2)26-21-12-16(8-9-20(21)25)10-11-22(3,4)24-13-17-6-5-7-19(23)18(17)14-24/h5-9,12,15,25H,10-11,13-14H2,1-4H3
Standard InChI Key: CZMKZNSLFDBBJT-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
8.4319 -18.7624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0275 -18.0566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6185 -18.7598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4890 -16.8349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4879 -17.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1959 -18.0634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9056 -17.6540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9027 -16.8313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1941 -16.4261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7812 -16.4265 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6139 -18.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3210 -17.6518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7364 -17.6495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7798 -18.0625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7792 -18.8797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0712 -19.2877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4866 -19.2888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4799 -17.9808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8212 -16.8338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6212 -16.6656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0264 -17.3748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8413 -17.3774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2520 -16.6717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8418 -15.9618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0282 -15.9626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2476 -18.0865 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
7 11 1 0
11 12 1 0
12 2 1 0
2 13 1 0
5 14 1 0
14 15 1 0
15 16 1 0
15 17 1 0
13 18 1 0
18 21 1 0
20 19 1 0
19 13 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
22 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 357.47Molecular Weight (Monoisotopic): 357.2104AlogP: 5.05#Rotatable Bonds: 6Polar Surface Area: 32.70Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.26CX Basic pKa: 7.77CX LogP: 5.28CX LogD: 4.75Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.79Np Likeness Score: -0.45
References 1. Rishton GM, Look GC, Ni ZJ, Zhang J, Wang Y, Huang Y, Wu X, Izzo NJ, LaBarbera KM, Limegrover CS, Rehak C, Yurko R, Catalano SM.. (2021) Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease., 12 (9.0): [PMID:34531947 ] [10.1021/acsmedchemlett.1c00048 ]